EMA: scaling for AUC = utopia [BE/BA News]

posted by Helmut Homepage – Vienna, Austria, 2021-08-03 14:54 (987 d 00:55 ago) – Posting: # 22501
Views: 3,129

Hi kratos,

❝ Just wanted to understand if the EMA would also start accepting scaling for AUC;

❝ There are several locally acting products where the AUC could be more variable than the Cmax parameter.


Correct.

❝ At the moment it appears only the EMA has restricted scaling to Cmax parameter …


Almost correct. Acceptable for MR products’ partial AUCs and Cτ,ss as well.

❝ … while other agencies have extended it to AUC as well.


Which ones? At least, none of the ones applying Average Bioequivalence with Expanding Limits (ABEL). Given, Health Canada accepts ABEL for AUC only.
Reference-scaled Average Bioequivalence (RSABE) – acceptable by the U.S. FDA and China’s CDE for any PK metric – is another cup of tea.

❝ Please, your thoughts on the same.


IMHO, it’s high time to revise the EMA’s GL of 2010. The mills of God grind slowly.
Perhaps the ICH works faster.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,984 posts in 4,822 threads, 1,651 registered users;
60 visitors (0 registered, 60 guests [including 7 identified bots]).
Forum time: 15:49 CEST (Europe/Vienna)

You can’t fix by analysis
what you bungled by design.    Richard J. Light, Judith D. Singer, John B. Willett

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5